Enliven Therapeutics, Inc. (Enliven or the Company) (Nasdaq: ELVN), a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced ...

Show More All authors: Washington University School of Medicine, St Louis, MO. A currently 74-year-old white woman with hypertension, hypothyroidism, and diabetes mellitus type 2 presented initially ...